The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Blood Plasma Products-Global Market Insights and Sales Trends 2025
Synopsis
Plasma, the major component of blood, is vital to the regulation of body functions. Blood plasma consists of several useful components such as albumin, coagulation factors, protease inhibitors and immunoglobulins. Since deficiencies in a component can result in the onset of a disease, both basic and targeted R&D has accelerated in this area. Blood plasma is part of an effective therapeutic treatment plan in various therapies due to its potential in battling several chronic and life-threatening diseases
The global Blood Plasma Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Blood Plasma Products in various end use industries. The expanding demands from the Hospitals And Clinics, Research Laboratories and Academic Institutions,, are propelling Blood Plasma Products market. Immunoglobulins, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Coagulation Factor Concentrates segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Plasma Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Plasma Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Plasma Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Plasma Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Plasma Products covered in this report include CSL Ltd., Creat Group Corporation, Grifols SA, Takeda, Octapharma AG, Kedrion SpA, Biotest AG, China Biologic Products and Sanquin, etc.
The global Blood Plasma Products market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Ltd.
Creat Group Corporation
Grifols SA
Takeda
Octapharma AG
Kedrion SpA
Biotest AG
China Biologic Products
Sanquin
LFB S.A.
Global Blood Plasma Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Plasma Products market, Segment by Type:
Immunoglobulins
Coagulation Factor Concentrates
Other
Global Blood Plasma Products market, by Application
Hospitals And Clinics
Research Laboratories
Academic Institutions
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Plasma Products companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Plasma, the major component of blood, is vital to the regulation of body functions. Blood plasma consists of several useful components such as albumin, coagulation factors, protease inhibitors and immunoglobulins. Since deficiencies in a component can result in the onset of a disease, both basic and targeted R&D has accelerated in this area. Blood plasma is part of an effective therapeutic treatment plan in various therapies due to its potential in battling several chronic and life-threatening diseases
The global Blood Plasma Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Blood Plasma Products in various end use industries. The expanding demands from the Hospitals And Clinics, Research Laboratories and Academic Institutions,, are propelling Blood Plasma Products market. Immunoglobulins, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Coagulation Factor Concentrates segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Blood Plasma Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Blood Plasma Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Blood Plasma Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Blood Plasma Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Blood Plasma Products covered in this report include CSL Ltd., Creat Group Corporation, Grifols SA, Takeda, Octapharma AG, Kedrion SpA, Biotest AG, China Biologic Products and Sanquin, etc.
The global Blood Plasma Products market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Ltd.
Creat Group Corporation
Grifols SA
Takeda
Octapharma AG
Kedrion SpA
Biotest AG
China Biologic Products
Sanquin
LFB S.A.
Global Blood Plasma Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Blood Plasma Products market, Segment by Type:
Immunoglobulins
Coagulation Factor Concentrates
Other
Global Blood Plasma Products market, by Application
Hospitals And Clinics
Research Laboratories
Academic Institutions
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Blood Plasma Products companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Blood Plasma Products
1.1 Blood Plasma Products Market Overview
1.1.1 Blood Plasma Products Product Scope
1.1.2 Blood Plasma Products Market Status and Outlook
1.2 Global Blood Plasma Products Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Blood Plasma Products Market Size by Region (2018-2029)
1.4 Global Blood Plasma Products Historic Market Size by Region (2018-2023)
1.5 Global Blood Plasma Products Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Blood Plasma Products Market Size (2018-2029)
1.6.1 North America Blood Plasma Products Market Size (2018-2029)
1.6.2 Europe Blood Plasma Products Market Size (2018-2029)
1.6.3 Asia-Pacific Blood Plasma Products Market Size (2018-2029)
1.6.4 Latin America Blood Plasma Products Market Size (2018-2029)
1.6.5 Middle East & Africa Blood Plasma Products Market Size (2018-2029)
2 Blood Plasma Products Market by Type
2.1 Introduction
2.1.1 Immunoglobulins
2.1.2 Coagulation Factor Concentrates
2.1.3 Other
2.2 Global Blood Plasma Products Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Blood Plasma Products Historic Market Size by Type (2018-2023)
2.2.2 Global Blood Plasma Products Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Blood Plasma Products Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Blood Plasma Products Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Blood Plasma Products Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Blood Plasma Products Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Blood Plasma Products Revenue Breakdown by Type (2018-2029)
3 Blood Plasma Products Market Overview by Application
3.1 Introduction
3.1.1 Hospitals And Clinics
3.1.2 Research Laboratories
3.1.3 Academic Institutions
3.2 Global Blood Plasma Products Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Blood Plasma Products Historic Market Size by Application (2018-2023)
3.2.2 Global Blood Plasma Products Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Blood Plasma Products Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Blood Plasma Products Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Blood Plasma Products Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Blood Plasma Products Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Blood Plasma Products Revenue Breakdown by Application (2018-2029)
4 Blood Plasma Products Competition Analysis by Players
4.1 Global Blood Plasma Products Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Plasma Products as of 2022)
4.3 Date of Key Players Enter into Blood Plasma Products Market
4.4 Global Top Players Blood Plasma Products Headquarters and Area Served
4.5 Key Players Blood Plasma Products Product Solution and Service
4.6 Competitive Status
4.6.1 Blood Plasma Products Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 CSL Ltd.
5.1.1 CSL Ltd. Profile
5.1.2 CSL Ltd. Main Business
5.1.3 CSL Ltd. Blood Plasma Products Products, Services and Solutions
5.1.4 CSL Ltd. Blood Plasma Products Revenue (US$ Million) & (2018-2023)
5.1.5 CSL Ltd. Recent Developments
5.2 Creat Group Corporation
5.2.1 Creat Group Corporation Profile
5.2.2 Creat Group Corporation Main Business
5.2.3 Creat Group Corporation Blood Plasma Products Products, Services and Solutions
5.2.4 Creat Group Corporation Blood Plasma Products Revenue (US$ Million) & (2018-2023)
5.2.5 Creat Group Corporation Recent Developments
5.3 Grifols SA
5.3.1 Grifols SA Profile
5.3.2 Grifols SA Main Business
5.3.3 Grifols SA Blood Plasma Products Products, Services and Solutions
5.3.4 Grifols SA Blood Plasma Products Revenue (US$ Million) & (2018-2023)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Blood Plasma Products Products, Services and Solutions
5.4.4 Takeda Blood Plasma Products Revenue (US$ Million) & (2018-2023)
5.4.5 Takeda Recent Developments
5.5 Octapharma AG
5.5.1 Octapharma AG Profile
5.5.2 Octapharma AG Main Business
5.5.3 Octapharma AG Blood Plasma Products Products, Services and Solutions
5.5.4 Octapharma AG Blood Plasma Products Revenue (US$ Million) & (2018-2023)
5.5.5 Octapharma AG Recent Developments
5.6 Kedrion SpA
5.6.1 Kedrion SpA Profile
5.6.2 Kedrion SpA Main Business
5.6.3 Kedrion SpA Blood Plasma Products Products, Services and Solutions
5.6.4 Kedrion SpA Blood Plasma Products Revenue (US$ Million) & (2018-2023)
5.6.5 Kedrion SpA Recent Developments
5.7 Biotest AG
5.7.1 Biotest AG Profile
5.7.2 Biotest AG Main Business
5.7.3 Biotest AG Blood Plasma Products Products, Services and Solutions
5.7.4 Biotest AG Blood Plasma Products Revenue (US$ Million) & (2018-2023)
5.7.5 Biotest AG Recent Developments
5.8 China Biologic Products
5.8.1 China Biologic Products Profile
5.8.2 China Biologic Products Main Business
5.8.3 China Biologic Products Blood Plasma Products Products, Services and Solutions
5.8.4 China Biologic Products Blood Plasma Products Revenue (US$ Million) & (2018-2023)
5.8.5 China Biologic Products Recent Developments
5.9 Sanquin
5.9.1 Sanquin Profile
5.9.2 Sanquin Main Business
5.9.3 Sanquin Blood Plasma Products Products, Services and Solutions
5.9.4 Sanquin Blood Plasma Products Revenue (US$ Million) & (2018-2023)
5.9.5 Sanquin Recent Developments
5.10 LFB S.A.
5.10.1 LFB S.A. Profile
5.10.2 LFB S.A. Main Business
5.10.3 LFB S.A. Blood Plasma Products Products, Services and Solutions
5.10.4 LFB S.A. Blood Plasma Products Revenue (US$ Million) & (2018-2023)
5.10.5 LFB S.A. Recent Developments
6 North America
6.1 North America Blood Plasma Products Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Blood Plasma Products Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Products Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Blood Plasma Products Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Products Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Blood Plasma Products Market Dynamics
11.1 Blood Plasma Products Industry Trends
11.2 Blood Plasma Products Market Drivers
11.3 Blood Plasma Products Market Challenges
11.4 Blood Plasma Products Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
